CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-30 | Patton Cynthia M SVP & CCO | Sale | −5,749 | $208.07 | $1.2M | 26,899 |
| 2019-08-30 | Patton Cynthia M SVP & CCO | Sale | −2,875 | $208.07 | $598K | 26,899 |
| 2019-08-30 | Patton Cynthia M SVP & CCO | Sale | −4,802 | $208.07 | $999K | 22,097 |
| 2019-08-07 | Williams R Sanders Director | Sale | −425 | $183.04 | $78K | 5,838 |
| 2019-08-07 | SUGAR RONALD D Director | Sale | −2,000 | $183.04 | $366K | 14,336 |
| 2019-07-03 | SUGAR RONALD D Director | Sale | −2,000 | $187.58 | $375K | 14,336 |
| 2019-06-05 | SUGAR RONALD D Director | Sale | −2,000 | $175.68 | $351K | 14,219 |
| 2019-05-01 | SUGAR RONALD D Director | Sale | −2,000 | $175.73 | $351K | 13,092 |
| 2019-04-03 | SUGAR RONALD D Director | Sale | −2,000 | $193.18 | $386K | 13,092 |
| 2019-03-06 | SUGAR RONALD D Director | Sale | −2,000 | $188.88 | $378K | 12,988 |
| 2019-02-07 | SUGAR RONALD D Director | Sale | −2,000 | $190.00 | $380K | 12,988 |
| 2018-12-06 | Jacks Tyler Director | Sale | −20,000 | $195.41 | $3.9M | 8,979 |
| 2018-11-29 | Patton Cynthia M SVP & CCO | Sale | −1,777 | $202.88 | $361K | 21,313 |
| 2018-07-16 | Harper Sean E EVP, Research & Development | Sale | −1,525 | $195.71 | $298K | 56,082 |
| 2018-06-12 | Harper Sean E EVP, Research & Development | Sale | −1,525 | $184.27 | $281K | 57,510 |
| 2018-05-14 | Harper Sean E EVP, Research & Development | Sale | −1,525 | $174.10 | $266K | 59,035 |
| 2018-04-12 | Harper Sean E EVP, Research & Development | Sale | −1,525 | $172.68 | $263K | 56,788 |
| 2018-03-16 | Harper Sean E EVP, Research & Development | Sale | −1,525 | $189.75 | $289K | 65,682 |
Page 4 of 4 · 78 trades